Association between variants in < em > TCF7L2 < /em > , < em > CTRB1/2 < /em > , and < em > GLP-1R < /em > genes and response to therapy with glucagon-like peptide-1 receptor agonists

CONCLUSION: There is no evidence suggesting a role for the variants studied in response to GLP-1 RA therapy in people with T2DM. However, specific demographic and clinical factors may be related to a better response to treatment with these agents.PMID:38453649 | DOI:10.1080/00325481.2024.2328513

Source: Postgraduate Medicine - March 7, 2024 Category: Internal Medicine Authors: Artemis Kyriakidou Angeliki V Kyriazou Theocharis Koufakis Yiannis Vasilopoulos Iakovos Avramidis Stefanos Baltagiannis Dimitrios G Goulis Kalliopi Kotsa Source Type: research